Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
UnitedHealth Group Incorporated logo
UNH
UnitedHealth Group Incorporated
20:00:02
400.96 $
0.0000 (%0.00)
Previous Close: 399.53
Day Low₺399.253
Day High₺406.18
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

UNH: UnitedHealth Group Incorporated Financials

UnitedHealth Group Incorporated Income Statement

Total revenue
Net income
Gross margin TTM
18.53%
Operating margin TTM
4.24%
Net profit margin TTM
2.69%
Return on investment TTM
12.81%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue447,567,000,000400,278,000,000371,622,000,000324,162,000,000
Operating income18,964,000,00032,287,000,00032,358,000,00028,435,000,000
Net income12,056,000,00014,405,000,00022,381,000,00020,120,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue447,567,000,000400,278,000,000371,622,000,000324,162,000,000
Cost of revenue364,650,000,000310,879,000,000280,664,000,000244,545,000,000
Gross profit82,917,000,00089,399,000,00090,958,000,00079,617,000,000
Research and development expenses0000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses0000
Other expenses63,953,000,00057,112,000,00058,600,000,00051,182,000,000
Operating expenses63,953,000,00057,112,000,00058,600,000,00051,182,000,000
Cost and expenses428,603,000,000367,991,000,000339,264,000,000295,727,000,000
Net interest income-4,002,000,000-3,906,000,000-3,246,000,000-2,092,000,000
Interest income0000
Interest expense4,002,000,0003,906,000,0003,246,000,0002,092,000,000
Depreciation and amortization4,361,000,0004,099,000,0003,972,000,0003,400,000,000
EBITDA23,060,000,00028,076,000,00036,330,000,00031,835,000,000
EBIT18,699,000,00023,977,000,00032,358,000,00028,435,000,000
Non-operating income (excl. interest)265,000,0008,310,000,00000
Operating income18,964,000,00032,287,000,00032,358,000,00028,435,000,000
Total other income/expenses (net)-4,267,000,000-12,216,000,000-3,246,000,000-2,092,000,000
Income before tax14,697,000,00020,071,000,00029,112,000,00026,343,000,000
Income tax expense1,890,000,0004,829,000,0005,968,000,0005,704,000,000
Net income from continuing operations12,807,000,00015,242,000,00023,144,000,00020,639,000,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income12,056,000,00014,405,000,00022,381,000,00020,120,000,000
Net income deductions0000
Bottom line net income12,056,000,00014,405,000,00022,381,000,00020,120,000,000
EPS13162422
Diluted EPS13162421
Weighted average shares outstanding910,000,000929,000,000928,000,000934,000,000
Weighted average diluted shares outstanding910,000,000929,000,000938,000,000950,000,000

UnitedHealth Group Incorporated Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
72,320,000,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets309,581,000,000298,278,000,000273,720,000,000245,705,000,000
Total liabilities207,883,000,000195,687,000,000174,801,000,000159,358,000,000
Total equity94,110,000,00092,658,000,00088,756,000,00077,772,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents24,365,000,00025,312,000,00025,427,000,00023,365,000,000
Short-term investments3,756,000,0003,801,000,0004,201,000,0004,546,000,000
Cash and short-term investments28,121,000,00029,113,000,00029,628,000,00027,911,000,000
Net receivables52,715,000,00048,454,000,00038,970,000,00030,450,000,000
Accounts receivable23,018,000,00022,365,000,00021,276,000,00017,681,000,000
Other receivables29,697,000,00026,089,000,00017,694,000,00012,769,000,000
Inventory0000
Prepaid expenses9,746,000,000000
Other current assets08,212,000,0009,839,000,00010,708,000,000
Total current assets90,582,000,00085,779,000,00078,437,000,00069,069,000,000
Property, plant and equipment (net)10,762,000,00010,553,000,00011,450,000,00010,128,000,000
Goodwill110,499,000,000106,734,000,000103,732,000,00093,352,000,000
Intangible assets20,474,000,00023,268,000,00015,194,000,00014,401,000,000
Goodwill and intangible assets130,973,000,000130,002,000,000118,926,000,000107,753,000,000
Long-term investments54,251,000,00052,354,000,00047,609,000,00043,728,000,000
Tax assets0002,769,000,000
Other non-current assets23,013,000,00019,590,000,00017,298,000,00012,258,000,000
Total non-current assets218,999,000,000212,499,000,000195,283,000,000176,636,000,000
Other assets0000
Total assets309,581,000,000298,278,000,000273,720,000,000245,705,000,000
Total payables77,369,000,00068,561,000,00031,958,000,00056,771,000,000
Accounts payable38,032,000,00068,561,000,00031,958,000,00056,771,000,000
Other payables39,337,000,000000
Accrued expenses0000
Short-term debt6,069,000,0004,545,000,0005,312,000,0003,110,000,000
Capital lease obligations (current)0000
Tax payables0000
Deferred revenue3,413,000,0003,317,000,0003,355,000,0003,075,000,000
Other current liabilities28,046,000,00027,346,000,00058,429,000,00026,281,000,000
Total current liabilities114,897,000,000103,769,000,00099,054,000,00089,237,000,000
Long-term debt72,320,000,00072,359,000,00058,263,000,00054,513,000,000
Capital lease obligations (non-current)003,860,000,0000
Deferred revenue (non-current)2,421,000,00003,355,000,0000
Deferred tax liabilities (non-current)03,620,000,0003,021,000,0002,769,000,000
Other non-current liabilities18,245,000,00015,939,000,00011,943,000,00012,839,000,000
Total non-current liabilities92,986,000,00091,918,000,00080,442,000,00070,121,000,000
Other liabilities00-4,695,000,0000
Capital lease obligations003,860,000,0000
Total liabilities207,883,000,000195,687,000,000174,801,000,000159,358,000,000
Treasury stock0000
Preferred stock0000
Common stock9,000,0009,000,0009,000,0009,000,000
Retained earnings95,603,000,00096,036,000,00095,774,000,00086,156,000,000
Additional paid-in capital559,000,000000
Accumulated other comprehensive income/loss-2,061,000,000-3,387,000,000-7,027,000,000-8,393,000,000
Other stockholders' equity0000
Total stockholders' equity94,110,000,00092,658,000,00088,756,000,00077,772,000,000
Total equity101,698,000,000102,591,000,00098,919,000,00086,347,000,000
Minority interest7,588,000,0009,933,000,00010,163,000,0008,575,000,000
Total liabilities and total equity309,581,000,000298,278,000,000273,720,000,000245,705,000,000
Total investments58,007,000,00056,155,000,00051,810,000,00048,274,000,000
Total debt78,389,000,00076,904,000,00067,435,000,00057,623,000,000
Net debt54,024,000,00051,592,000,00042,008,000,00034,258,000,000

UnitedHealth Group Incorporated Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations19,697,000,00024,204,000,00029,068,000,00026,206,000,000
Cash from investing-8,685,000,000-20,527,000,000-15,574,000,000-28,476,000,000
Cash from financing-11,644,000,000-3,512,000,000-11,529,000,0004,226,000,000
Net change in cash2,809,000,000-115,000,0002,062,000,0001,990,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income12,807,000,00015,242,000,00022,381,000,00020,120,000,000
Depreciation and amortization4,361,000,0004,099,000,0003,972,000,0003,400,000,000
Deferred income tax-989,000,000-296,000,000-245,000,000-673,000,000
Stock-based compensation971,000,0001,018,000,0001,059,000,000925,000,000
Change in working capital2,282,000,000-808,000,0001,643,000,0002,246,000,000
Accounts receivable0-1,437,000,000-3,114,000,000-2,523,000,000
Inventory001,038,000,0000
Accounts payable02,463,000,0003,516,000,0001,964,000,000
Other working capital2,282,000,000-1,834,000,000203,000,0002,805,000,000
Other non-cash items265,000,0004,949,000,000258,000,000188,000,000
Net cash from operating activities19,697,000,00024,204,000,00029,068,000,00026,206,000,000
Investments in property, plant and equipment-3,622,000,000-3,499,000,000-3,386,000,000-2,802,000,000
Acquisitions (net)-4,509,000,000-13,408,000,000-10,136,000,000-21,458,000,000
Purchases of investments0-27,308,000,000-18,314,000,000-18,825,000,000
Sales/maturities of investments361,000,00027,833,000,00016,537,000,00011,988,000,000
Other investing activities-915,000,000-4,145,000,000-275,000,0002,621,000,000
Net cash from investing activities-8,685,000,000-20,527,000,000-15,574,000,000-28,476,000,000
Net debt issuance726,000,00014,660,000,0004,280,000,00012,536,000,000
Long-term net debt issuance014,811,000,0004,269,000,00011,804,000,000
Short-term net debt issuance726,000,000-151,000,00011,000,000732,000,000
Net stock issuance-5,545,000,000-7,154,000,000-6,647,000,000-5,747,000,000
Net common stock issuance-5,545,000,000-7,154,000,000-6,647,000,000-5,747,000,000
Common stock issuance01,846,000,0001,353,000,0001,253,000,000
Common stock repurchased-5,545,000,000-9,000,000,000-8,000,000,000-7,000,000,000
Net preferred stock issuance0000
Net dividends paid-7,916,000,000-7,533,000,000-6,761,000,000-5,991,000,000
Common dividends paid-7,916,000,000-7,533,000,000-6,761,000,000-5,991,000,000
Preferred dividends paid0000
Other financing activities1,091,000,000-3,485,000,000-2,401,000,0003,428,000,000
Net cash from financing activities-11,644,000,000-3,512,000,000-11,529,000,0004,226,000,000
Effect of FX changes on cash3,441,000,000-280,000,00097,000,00034,000,000
Net change in cash2,809,000,000-115,000,0002,062,000,0001,990,000,000
Cash at end of period28,121,000,00025,312,000,00025,427,000,00023,365,000,000
Cash at beginning of period25,312,000,00025,427,000,00023,365,000,00021,375,000,000
Operating cash flow19,697,000,00024,204,000,00029,068,000,00026,206,000,000
Capital expenditure-3,622,000,000-3,499,000,000-3,386,000,000-2,802,000,000
Free cash flow16,075,000,00020,705,000,00025,682,000,00023,404,000,000
Income taxes paid04,620,000,0006,078,000,0005,222,000,000
Interest paid03,594,000,0003,035,000,0001,945,000,000